Sanofi SA
(LTS:0A2V)
$
49
0 (0%)
Market Cap: 122.85 Bil
Enterprise Value: 141.18 Bil
PE Ratio: 28.19
PB Ratio: 1.63
GF Score: 87/100 
Sanofi SA at Credit Suisse London Global Healthcare Conference (Virtual) Transcript
Mar 02, 2022 / 02:00PM GMT
Release Date Price:
$50.97
(-0.18%)
Matthew Weston;dit Suisse AG
CrÃ;Research Division - MD and Co-Head of European Pharmaceutical Equity Research
© -
Good afternoon, everyone, and welcome to our next fireside chat at the Credit Suisse London Healthcare Conference. My name is Matthew Weston from the European pharma research team. I'm joined by my colleague, Jo Walton. And it's a great pleasure today to welcome Dietmar Berger, the Global Head of Development at Sanofi for the next fireside chat. Dietmar is also joined by the Investor Relations team at Sanofi. Dietmar, thank you for taking the time.
Dietmar P. Berger
Sanofi - Chief Medical Officer & Global Head of Development
Thank you, Matt.
Matthew Weston;dit Suisse AG
CrÃ;Research Division - MD and Co-Head of European Pharmaceutical Equity Research
© -
(Operator Instructions) But we do have some questions of our own and we'll start with those. Jo, over to you.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers